Fordyce Marshall — SEC Form 4 filings
SEC reporting owner CIK 1859453. 26 Form 4 filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 26 filings on record, filed 2024-01-18 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 76 legs across 23 filings — 499,730 shares, $20,339,840 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 93.
- Largest priced transaction: sale of 32,550 shares @ $42.07 ($1,369,496) in Vera Therapeutics, Inc., filed 2026-08-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | PRESIDENT AND CEO, Director | 26 | — | 76 legs · 499,730 sh · $20,339,840 | 93 |
Form 4 filings — Fordyce Marshall
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 18,500 @ $2.90 · Sale (S): 18,500 @ $37 · Option exercise (M): 18,500 (derivative) @ $0 | EDGAR |
| 2026-09-04 | 4 | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 18,500 @ $2.90 · Sale (S): 18,500 @ $35.12 · Option exercise (M): 18,500 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4/A | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 18,500 @ $2.90 · Sale (S): 18,412 @ $37.93 · Sale (S): 88 @ $38.43 · Option exercise (M): 18,500 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4/A | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 18,500 @ $2.90 · Sale (S): 14,219 @ $36.64 · Sale (S): 4,281 @ $37.09 · Option exercise (M): 18,500 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4/A | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 46,250 @ $2.90 · Sale (S): 1,000 @ $40.78 · Sale (S): 32,550 @ $42.07 · Sale (S): 10,500 @ $42.86 · Sale (S): 2,200 @ $43.59 · Option exercise (M): 46,250 (derivative) @ $0 | EDGAR |
| 2026-07-09 | 4 | Vera Therapeutics, Inc. (VERA) | Sale (S): 1,000 @ $40.78 · Sale (S): 32,550 @ $42.07 · Sale (S): 10,500 @ $42.86 · Sale (S): 2,200 @ $43.59 | EDGAR |
| 2026-06-24 | 4 | Vera Therapeutics, Inc. (VERA) | Sale (S): 18,412 @ $37.93 · Sale (S): 88 @ $38.43 | EDGAR |
| 2026-05-13 | 4 | Vera Therapeutics, Inc. (VERA) | Sale (S): 14,219 @ $36.64 · Sale (S): 4,281 @ $37.09 | EDGAR |
| 2026-04-15 | 4 | Vera Therapeutics, Inc. (VERA) | Sale (S): 14,130 @ $43.66 · Sale (S): 7,921 @ $44.58 · Sale (S): 900 @ $45.51 | EDGAR |
| 2026-02-25 | 4 | Vera Therapeutics, Inc. (VERA) | Sale (S): 16,925 @ $41.98 | EDGAR |
| 2026-02-06 | 4 | Vera Therapeutics, Inc. (VERA) | Grant/award (A): 68,800 @ $0 · Grant/award (A): 137,500 (derivative) @ $0 | EDGAR |
| 2025-02-27 | 4 | Vera Therapeutics, Inc. (VERA) | Sale (S): 10,613 @ $27.89 · Sale (S): 7,975 @ $27.55 · Sale (S): 1,100 @ $28.32 | EDGAR |
| 2025-02-20 | 4 | Vera Therapeutics, Inc. (VERA) | Grant/award (A): 80,750 @ $0 · Grant/award (A): 161,500 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 9,975 @ $2.90 · Sale (S): 9,975 @ $41.53 · Option exercise (M): 5,650 @ $2.90 · Sale (S): 5,650 @ $42.03 · Option exercise (M): 1,875 @ $2.90 · Sale (S): 1,875 @ $42 · +2 more | EDGAR |
| 2024-12-20 | 4 | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 3,772 @ $2.90 · Sale (S): 3,772 @ $41.33 · Option exercise (M): 2,195 @ $2.90 · Sale (S): 2,195 @ $42.35 · Option exercise (M): 5,023 @ $2.90 · Sale (S): 5,023 @ $43.52 · +8 more | EDGAR |
| 2024-12-13 | 4 | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 14,925 @ $2.90 · Sale (S): 14,925 @ $46.91 · Option exercise (M): 700 @ $2.90 · Sale (S): 700 @ $47.55 · Option exercise (M): 1,775 @ $2.90 · Sale (S): 1,775 @ $46.94 · +4 more | EDGAR |
| 2024-11-27 | 4 | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 6,579 @ $2.90 · Sale (S): 6,579 @ $47.05 · Option exercise (M): 7,665 @ $2.90 · Sale (S): 7,665 @ $48.18 · Option exercise (M): 1,381 @ $2.90 · Sale (S): 1,381 @ $48.80 · +7 more | EDGAR |
| 2024-11-15 | 4 | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 12,218 @ $2.90 · Sale (S): 12,218 @ $49.54 · Option exercise (M): 3,307 @ $2.90 · Sale (S): 3,307 @ $50.28 · Option exercise (M): 100 @ $2.90 · Sale (S): 100 @ $51.20 · +18 more | EDGAR |
| 2024-10-25 | 4 | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 12,715 @ $2.90 · Sale (S): 12,715 @ $39.80 · Option exercise (M): 2,310 @ $2.90 · Sale (S): 2,310 @ $40.70 · Option exercise (M): 600 @ $2.90 · Sale (S): 600 @ $41.61 · +5 more | EDGAR |
| 2024-10-11 | 4 | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 12,273 @ $2.90 · Sale (S): 12,273 @ $38.08 · Option exercise (M): 3,352 @ $2.90 · Sale (S): 3,352 @ $38.83 · Option exercise (M): 15,625 (derivative) @ $0 | EDGAR |
| 2024-09-27 | 4 | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 8,643 @ $2.90 · Sale (S): 8,643 @ $45.42 · Option exercise (M): 4,817 @ $2.90 · Sale (S): 4,817 @ $46.62 · Option exercise (M): 2,165 @ $2.90 · Sale (S): 2,165 @ $47.06 · +21 more | EDGAR |
| 2024-09-13 | 4 | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 9,274 @ $2.90 · Sale (S): 9,274 @ $37.31 · Option exercise (M): 6,351 @ $2.90 · Sale (S): 6,351 @ $37.78 · Option exercise (M): 15,625 (derivative) @ $0 | EDGAR |
| 2024-08-30 | 4 | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 14,925 @ $2.90 · Sale (S): 14,925 @ $36.80 · Option exercise (M): 700 @ $2.90 · Sale (S): 700 @ $37.54 · Sale (S): 13,995 @ $36.82 · Sale (S): 700 @ $37.53 · +1 more | EDGAR |
| 2024-08-23 | 4 | Vera Therapeutics, Inc. (VERA) | Sale (S): 14,471 @ $39.76 | EDGAR |
| 2024-08-16 | 4 | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 15,625 @ $2.90 · Sale (S): 15,625 @ $37.56 · Option exercise (M): 15,625 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | Vera Therapeutics, Inc. (VERA) | Grant/award (A): 78,750 @ $0 · Grant/award (A): 292,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1859453 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →